30 Apr

Analysts Raise Columbia’s Price Target after Its Q1 Results

WRITTEN BY Sharon Bailey

Analysts’ reaction to Columbia’s first-quarter results

Several analysts raised their price targets for Columbia Sportswear (COLM) after the company reported strong first-quarter earnings results and raised its 2019 outlook. Columbia Sportswear declared its results after the markets closed on April 25. The company’s stock rose 2.4% in after-market trading on April 25 but fell 3.1% on April 26.

After the results, the following analysts increased COLM’s price target:

  • Canaccord Genuity: $107 from $104
  • D.A. Davidson: $129 from $116
  • Cowen and Company: $123 from $120
  • B. Riley: $107 from $96
  • Wedbush: $118 from $113
  • Guggenheim: $125 from $120
  • Stifel: $128 from $120

Analysts Raise Columbia’s Price Target after Its Q1 Results

Sign up for Bagels & Stox, our witty take on the top market and investment news, straight to your inbox! Whether you’re a serious investor or just want to be informed, Bagels & Stox will be your favorite email.

Columbia Sportswear’s adjusted EPS rose 39% year-over-year to $1.07 driven by 7.8% sales growth, enhanced margins, and higher net interest income. The company’s first-quarter EPS crushed analysts’ estimate of $0.83. Its earnings also gained from its buyout of its Chinese joint venture, which became a wholly owned subsidiary in January 2019.

Following its performance in the first quarter, Columbia Sportswear raised its EPS outlook for 2019 to the $4.40–$4.55 range. The company’s previously issued outlook range was $4.30–$4.45.

Year-to-date movement

On April 26, Columbia Sportswear stock was up 20.4% on a year-to-date basis compared to the 19.1% rise in Nike (NKE) and the 36.1% rise in Skechers (SKX).

After the price target revisions mentioned above, the 12-month average price target for Columbia Sportswear stock is $116.77. Analysts’ average price target reflects a potential upside of 15% compared to the stock’s closing price of $101.25 on April 26.

On April 26, nine out of 15 analysts considered Columbia Sportswear a “buy,” while the remaining six had given it “hold” recommendations.

Latest articles

On October 17, Cannabis 2.0 legalized edibles, beverages, and concentrates in Canada. As the country waits for the benefits, is Cannabis 3.0 next?

Prohibition Partners expects that by 2024, the legal cannabis market could reach $103.9 billion and the medical cannabis market could reach $62.6 billion.

The cannabis sector was trading in the red today. MKM Partners lowered its revenue estimates for Canopy Growth (CGC) (WEED) and Aurora Cannabis (ACB).

Ford plans to unveil its crossover SUV, the Mach-E, on November 17. Ford committed $11.5 billion toward the electrification of its fleet through 2022.

This week is important for the cannabis sector, as Canopy Growth and Aurora Cannabis are both set to report their earnings results on November 14.

Currently, 33 states and Washington, D.C., have legalized medical cannabis, but it's illegal in Kansas. Even having a small amount is considered a crime.